MCKESSON CORP (MCK)
Wholesale-Drugs, Proprietaries & Druggists' Sundries · Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE
$869.26
+1.09%
Investingg Score
57.9 / 100
Hold
Business overview
- Gross margin is reported at 3.6%
- Operating margin stands at 1.5%
- Free cash flow margin is recorded at 1.4%
These low percentage margins reflect the high-volume, thin-margin nature of pharmaceutical wholesale operations.
Financial health
- Balance sheet pillar score is 64 out of 100
- Risk pillar score reaches the maximum of 100
The supportive balance sheet score and top-tier risk score indicate sound financial positioning with limited near-term distress indicators.
- Gross Margin
- 3.6%
- Operating Margin
- 1.5%
- Current Ratio
- 0.9x
- Debt / Equity
- -3.00
- Free Cash Flow (TTM)
- $5.7B
- Interest Coverage
- Data unavailable
Valuation
- EV to EBITDA ratio is 0.42
- P/E ratio is Data unavailable
- FCF yield is Data unavailable
The exceptionally low EV to EBITDA ratio points toward unique valuation metrics, but missing P/E and yield figures introduce uncertainty.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- 0.4x
- FCF Yield
- Data unavailable
Key risks
- Operating margins are thin at 1.5%, leaving little room for cost inflation.
- Certain valuation metrics such as P/E and FCF yield are unavailable, creating informational gaps.
- The technical trend is currently Sideways despite trading above key moving averages.
Market cap $0 · data as of 2026-08-18
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze MCK with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.